As Sales Slip, Merck & Co. Plans 7,200 Job Cuts
This article was originally published in The Pink Sheet Daily
Executive Summary
Facing lower sales of Vytorin, Singulair and Gardasil, on top of recent pipeline disappointments, Merck implements a new restructuring initiative.